Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
NCT06987669 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 155
Last updated 2025-05-23
Summary
This observational study aims to determine the gastric emptying kinetics assessed by ultrasound in healthy volunteers after a standard breakfast and the state of the stomach after a clear liquid diet for 18 /24 hours in patients on GLP-1 agonist. The main questions it seeks to answer are:
* Is the kinetic after a standard breakfast that includes ( avocado and eggs: high fat) as fast as a standard meal that does not involve this food?
* Is a clear liquid diet of 18 to 24 hours enough to be an empty-stomach, assessed by Ultrasound in patients on GLP1 agonist?
Participants will be asked to do:
-A baseline Gastric US will be performed for healthy volunteers, and then they will have a standardized breakfast. An hourly or bihourly assessment will be done by the US.
Conditions
- Diabetes Type 2
- Obesity and Overweight
Interventions
- DIAGNOSTIC_TEST
-
Gastric Ultrasound
A gastric ultrasound will be performed to determine the state of the stomach. Empty, clear fluids, solid, and in case of fluid, the amount of it ( using free tracing)
Sponsors & Collaborators
-
Clinica Alemana de Santiago
lead OTHER
Principal Investigators
-
Cristian Arzola, MD, MSc · Universidad de Toronto
-
Juan Pablo Ghiringelli · Universidad de Valparaiso
-
Miguel vega, MD · Universidad del Desarrollo
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-17
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
More Related Trials
-
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying
NCT07140289 ·Status: ENROLLING_BY_INVITATION
-
Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists
NCT05889637 ·Status: COMPLETED
-
Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
NCT06038734 ·Status: COMPLETED
-
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
NCT06500143 ·Status: COMPLETED
-
GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
NCT07251803 ·Status: RECRUITING
-
Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
NCT07276763 ·Status: NOT_YET_RECRUITING
-
Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Non-diabetic Controls
NCT03217630 ·Status: COMPLETED
-
Gastric Ultrasound in Patients Who Have Undergone Bariatric Surgery
NCT07310875 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study
NCT05569304 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Liraglutide on Body Surface Gastric Mapping
NCT06500130 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity
NCT02191501 ·Status: TERMINATED ·Phase: NA
-
Endoscopic Sleeve Gastroplasty for Treatment of Obesity
NCT02231970 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Role of Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injection in the Treatment of Obesity.
NCT03901040 ·Status: UNKNOWN ·Phase: NA
-
Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.
NCT07297238 ·Status: RECRUITING ·Phase: NA
-
ESG in Obese Adolescents
NCT06914765 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
NCT02417103 ·Status: TERMINATED ·Phase: PHASE3
-
SlimShape Device for Abdominal Fat and Circumference Reduction
NCT02999763 ·Status: COMPLETED ·Phase: NA
-
A Scintigraphic Study to Investigate the Effect of Gelesis100 on Gastric Emptying in Overweight and Obese Subjects
NCT02487602 ·Status: COMPLETED ·Phase: NA
-
Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure
NCT04502732 ·Status: TERMINATED
-
Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial
NCT05516576 ·Status: RECRUITING ·Phase: NA
-
3D Ultrasound Validation for Measuring Stomach Volume
NCT00588224 ·Status: COMPLETED
-
Medical Supervised Duodenal-Enteral Feeding Treatment
NCT03542864 ·Status: COMPLETED ·Phase: NA
-
Chewing, Swallowing and Orofacial Motricity in Severe Obese
NCT05516693 ·Status: UNKNOWN ·Phase: NA
-
Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions
NCT02888951 ·Status: UNKNOWN
-
Outcome of Gastric Fundus and Pylorus Botulinum Toxin A Injection
NCT04948177 ·Status: COMPLETED